Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants

• Meagan M. Jenkins,
• Donna Phan Tran,
• Evelyn A. Flores,
• Deborah Kupferwasser,
• Harry Pickering,
• Ying Zheng,
• David W. Gjertson,
• David W. Gjertson,
• Ted M. Ross,
• Ted M. Ross,
• Joanna M. Schaenman,
• Joanna M. Schaenman,
• Loren G. Miller,
• Loren G. Miller,
• Loren G. Miller,
• Michael R. Yeaman,
• Michael R. Yeaman,
• Michael R. Yeaman,
• Michael R. Yeaman,
• Elaine F. Reed

Affiliations

Meagan M. Jenkins

Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, United States

Donna Phan Tran

Lundquist Institute for Biomedical Innovation at Harbor–University of California, Los Angeles (UCLA) Medical Center, Torrance, CA, United States

Evelyn A. Flores

Lundquist Institute for Biomedical Innovation at Harbor–University of California, Los Angeles (UCLA) Medical Center, Torrance, CA, United States

Deborah Kupferwasser

Lundquist Institute for Biomedical Innovation at Harbor–University of California, Los Angeles (UCLA) Medical Center, Torrance, CA, United States

Harry Pickering

Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, United States

Ying Zheng

Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, United States

David W. Gjertson

Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, United States

David W. Gjertson

Department of Biostatistics, University of California Los Angeles, Los Angeles, CA, United States

Ted M. Ross

Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States

Ted M. Ross

Department of Infectious Diseases, University of Georgia, Athens, GA, United States

Joanna M. Schaenman

Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, United States

Joanna M. Schaenman

Division of Infectious Diseases, Department of Medicine, Harbor-University of California, Los Angeles (UCLA) Medical Center, Torrance, CA, United States

Loren G. Miller

Lundquist Institute for Biomedical Innovation at Harbor–University of California, Los Angeles (UCLA) Medical Center, Torrance, CA, United States

Loren G. Miller

Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, United States

Loren G. Miller

Division of Infectious Diseases, Department of Medicine, Harbor-University of California, Los Angeles (UCLA) Medical Center, Torrance, CA, United States

Michael R. Yeaman

Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, United States

Michael R. Yeaman

Division of Infectious Diseases, Department of Medicine, Harbor-University of California, Los Angeles (UCLA) Medical Center, Torrance, CA, United States

Michael R. Yeaman

Division of Molecular Medicine, Harbor–University of California, Los Angeles (UCLA) Medical Center, Torrance, CA, United States

Michael R. Yeaman

Institute for Infection & Immunity, Lundquist Institute for Biomedical Innovation at Harbor–University of California, Los Angeles (UCLA) Medical Center, Torrance, CA, United States

Elaine F. Reed

Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, United States